TFAP2C and neoplasm: In consistence with previous report in which knockdown of TFAP2C decreased the number of cells in S phase and delayed the growth of xenograft tumor in both E2− and E2 + conditions, we observed a reduction of cell viability in all six AFF4-knockout lines (Fig. 6b, c, Supplementary Fig. 5b, c).